Concepedia

Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond

Drucy Borowitz, Richard B. Parad, Jack Sharp, Kathryn A. Sabadosa, Karen A. Robinson, Michael J. Rock, Philip M. Farrell, Marci K. Sontag, Margaret Rosenfeld, Stephanie D. Davis,

The Journal of Pediatrics · 2009 · 212 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report

Philip M. Farrell, Beryl J. Rosenstein, Terry B. White et al. · The Journal of Pediatrics · 2008 · 1.1K citations · Full text

, , +9

Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas Deferens

Miguel Chillón, Teresa Casals, Bernard Mercier et al. · New England Journal of Medicine · 1995 · 967 citations · Full text

, , +11

Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis

Drucy Borowitz, Karen A. Robinson, Margaret Rosenfeld et al. · The Journal of Pediatrics · 2009 · 454 citations · Full text

, , +13

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.

Harry Cuppens, Wen‐chang Lin, Martine Jaspers et al. · Journal of Clinical Investigation · 1998 · 392 citations · Full text

, , +15

Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission

Lisa Saiman · American Journal of Infection Control · 2003 · 308 citations

, , +17